Investor relations

Seek to understand and meet shareholder needs and expectations (QCA Principle 3)

The Board is committed to maintaining open and transparent communication with shareholders regarding the Company’s strategy, performance and financial position. The Executive Chairman and Chief Executive Officer lead engagement with institutional investors and analysts, ensuring that shareholder feedback is communicated to the Board. The Company encourages shareholder participation at its Annual General Meeting and maintains an up-to-date investor section on its website, where regulatory announcements and financial reports are published.

Request a meeting with






    CelLBxHealth Logo
    Privacy overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.